Evidence map›Paper›PMID 23452899›Full record

ArticleBMC complementary and alternative medicine2013

In vitro biological effects of two anti-diabetic medicinal plants used in Benin as folk medicine.

Fifa T D Bothon, Eric Debiton, Felicien Avlessi, Christiane Forestier, Jean-Claude Teulade, Dominique K C Sohounhloue

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 79 citations in OpenAlex.

  1. Effects ofHeliyon · 2024
    Article
  2. Article
  3. Antioxidant and Anti-Diabetic Properties of Olive (Antioxidants (Basel, Switzerland) · 2023
    Article
  4. Comprehensive comparison of different parts ofFrontiers in plant science · 2023
    Article
  5. Efficacy ofMetabolism open · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Pharmaceutical biology · 2021
    Article
  10. Review
  11. Review
  12. Article
  13. Evaluation of Antioxidant Potentials andBioMed research international · 2017
    Article
  14. Article
  15. Article
  16. Biotechnology, biotechnological equipment · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Fifa T D BothonClermont University, Université d'Auvergne, IMTV, F-63000, Clermont-Ferrand, France.
Eric Debiton
Felicien Avlessi
Christiane Forestier
Jean-Claude Teulade
Dominique K C Sohounhloue
Université Clermont Auvergne · FRUniversité d'Abomey-Calavi · BJInserm · FRLaboratoire Microorganismes Génome et Environnement · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExtracts from Polygonum senegalensis (Polygonaceae) and Pseudocedrela kotschyi (Meliaceae) are two important traditionally used medicinal plants in rural Benin to treat many diseases and notably type 2 diabetes. The aim of the study was to investigate the α-glucosidase inhibition, antioxidant and antibacterial activities of those plants extract: Polygonum senegalensis leaves, and Pseudocedrela kotschyi root.

methodsHydro-alcoholic (50%) extracts were analyzed for their phytochemical content and tested for their inhibition potency on α-glucosidase from Saccharomyces cerevisiae. Antioxidant activities were assessed using the DPPH, ORAC, FRAP and DCFH-DA (cell based) assay. Finally, the antibacterial activity was evaluated using MIC determination on four Gram-positive cocci (Bacillus subtilis, Clostridium difficile, Enterococcus faecalis, Staphylococcus aureus), three Gram-negative bacilli (Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae), and the yeast Candida albicans.

resultsEach extract presented significant α-glucosidase inhibition and antioxidant activities. Polygonum senegalensis leaf extracts were the most active in each in vitro assay with an IC50 = 1.5 μg/ml for α-glucosidase inhibition and an IC50 = 6.8 μg/ml for DPPH scavenging, - 4.5 μmol Fe II/g of dry matter - 9366 μmol Trolox / g DW - for FRAP and ORAC values, respectively. IC50 = 2.3 μg GA / ml for DCFH-DA assay. Concerning its antibacterial activity, a growth inhibitory effect was observed only against three Gram negative bacilli: B. subtilis, E. faecalis, S. aureus and the yeast C. albicans at high concentration.

conclusionThe results showed that the semi alcoholic extract of the two studied plants possess α-glucosidase inhibitory activity, antioxidant potency, and low antibacterial effect.

Indexed as

Glycoside Hydrolase InhibitorsMeliaceaePolygonumAnti-Infective AgentsAntioxidantsBacteriaBeninCandida albicansDiabetes Mellitus, Type 2Enzyme InhibitorsFree RadicalsHumansHypoglycemic AgentsInhibitory Concentration 50Medicine, African TraditionalPhytotherapyAnti-Infective AgentsAntioxidantsEnzyme InhibitorsFree RadicalsGlycoside Hydrolase InhibitorsHypoglycemic AgentsPlant Extracts

Identifiers

PMID23452899
PMCPMC3599091
OpenAlexW2150837034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.